Biotechnology M&A » By The Online Investor Staff, updated Mon., Apr. 29, 11:38 AM
Recent mergers and acquisitions in the Biotechnology M&A category.
Slide #81. Thermo Fisher Scientific Inc. — One Lambda, Inc.
Acquirer: |
Thermo Fisher Scientific Inc. (NYSE:TMO) |
Acquiree: |
One Lambda, Inc. |
Details: |
Thermo Fisher Scientific Inc.has completed its previously announced acquisition of One Lambda, Inc., the leader in transplant diagnostics. Based in Canoga Park, Calif., One Lambda has approximately 320 employees and had 2011 revenue of $182 million. The business will become part of Thermo Fisher's Specialty Diagnostics Segment. |
Thermo Fisher Scientific is engaged in serving science. Co.'s segments include: Life Sciences Solutions, which provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines, and diagnosis of disease; Analytical Instruments, which provides instruments, consumables, software and services that are used for a range of applications in the laboratory, on the production line and in the field; and Specialty Diagnostics, which provides diagnostic test kits, reagents, culture media, instruments and associated products; and Laboratory Products and Biopharma Services, which provides virtually things needed for the laboratory.
Thermo Fisher Scientific SEC Filing Email Alerts Service
Open the TMO Page at The Online Investor »
Company Name: |
Thermo Fisher Scientific Inc |
Stock buyback: |
TMO buyback |
Website: |
www.thermofisher.com |
Sector: |
Biotechnology |
Number of ETFs Holding TMO: |
105 |
Total Market Value Held by ETFs: |
$25.59B |
Total Market Capitalization: |
$218.01B |
% of Market Cap. Held by ETFs: |
11.74% |
|
Open the TMO Page at The Online Investor (in a new window) »
|
April 29, 2024 11:38 AM Eastern
Buy (3.34 out of 4)
49th percentile
|
|